Comparative Pharmacology
Head-to-head clinical analysis: OPTIRAY 300 versus OPTIRAY 320.
Peer-Reviewed Evidence
Head-to-head clinical analysis: OPTIRAY 300 versus OPTIRAY 320.
OPTIRAY 300 vs OPTIRAY 320
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Optiray 300 (ioversol) is a nonionic iodinated contrast medium that attenuates X-rays, enhancing vascular and tissue contrast during imaging. It acts by increasing the density of blood vessels and tissues to X-rays, thereby improving visualization of anatomical structures.
Iodinated radiocontrast agent that attenuates X-rays and enhances vascular and tissue contrast during radiographic procedures.
Intravenous administration: 50-150 mL per injection (up to 250 mL for CT imaging). Typical adult dose: 1-2 mL/kg body weight (up to 150 mL) given as a bolus or rapid infusion. Intrathecal administration: 8-12 mL for myelography.
Intravenous administration: 50-150 mL of OPTIRAY 320 (ioversol 320 mg iodine/mL) per injection for contrast-enhanced CT; total dose not to exceed 250 mL. Intra-arterial: variable per procedure.
None Documented
None Documented
Terminal elimination half-life is approximately 1.5-2 hours in patients with normal renal function. In patients with impaired renal function, half-life may be prolonged significantly (up to 30 hours or more), necessitating dose adjustment or avoidance.
Terminal elimination half-life is approximately 2 hours in patients with normal renal function (creatinine clearance >60 mL/min). Prolonged in renal impairment; may exceed 20 hours in severe renal failure (CrCl <30 mL/min).
Primarily renal elimination via glomerular filtration; approximately 95-100% of the administered dose is excreted unchanged in urine within 24 hours. A negligible amount is eliminated via biliary/fecal routes (<1%).
Renal excretion of unchanged drug via glomerular filtration; approximately 95% eliminated in urine within 24 hours. Less than 1% excreted in feces via biliary route.
Category C
Category C
Radiological Contrast Agent
Radiological Contrast Agent